He Xue, Park Sujeong, Chen Yan, Lee Heedoo
Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Department of Biology and Chemistry, Changwon National University, Changwon, Korea.
Front Mol Biosci. 2021 Feb 24;8:630718. doi: 10.3389/fmolb.2021.630718. eCollection 2021.
Extracellular vesicles are cell-derived membranous vesicles that are secreted into biofluids. Emerging evidence suggests that EVs play an essential role in the pathogenesis of many diseases by transferring proteins, genetic material, and small signaling molecules between cells. Among these molecules, microRNAs (miRNAs), a type of small noncoding RNA, are one of the most important signals and are involved in various biological processes. Lung cancer is one of the leading causes of cancer-related deaths worldwide. Early diagnosis of lung cancer may help to reduce mortality and increase the 5 years survival rate and thereby reduce the associated socioeconomic burden. In the past, EV-miRNAs have been recognized as biomarkers of several cancers to assist in diagnosis or prognosis. In this review, we discuss recent findings and clinical practice for EV-miRNAs of lung cancer in several biofluids, including blood, bronchoalveolar lavage fluid (BALF), and pleural lavage.
细胞外囊泡是细胞来源的膜性囊泡,可分泌到生物流体中。新出现的证据表明,细胞外囊泡通过在细胞间传递蛋白质、遗传物质和小信号分子,在许多疾病的发病机制中发挥重要作用。在这些分子中,微小RNA(miRNA)是一种小的非编码RNA,是最重要的信号之一,参与各种生物学过程。肺癌是全球癌症相关死亡的主要原因之一。肺癌的早期诊断可能有助于降低死亡率,提高5年生存率,从而减轻相关的社会经济负担。过去,细胞外囊泡微小RNA已被认为是几种癌症的生物标志物,有助于诊断或预后评估。在这篇综述中,我们讨论了在几种生物流体(包括血液、支气管肺泡灌洗液(BALF)和胸腔灌洗液)中肺癌细胞外囊泡微小RNA的最新研究结果和临床应用。